Deliver Your News to the World

Clinical Research Consulting to Speak at the Medical Foods Industry Conference & Expo in Miami Beach on August 6-7

Alan S. Ryan, Ph.D., CEO at Clinical Research Consulting will present on the clinical research and product development opportunities for medical foods. New medical food products containing omega-3 fatty acids will be described for a variety of medical conditions.


New York / NY / USA – WEBWIRE
Medical Foods Industry Conference & Expo ( MFICE )
Medical Foods Industry Conference & Expo ( MFICE )

New York, NY--Ticonderoga Ventures, Inc. announces that Clinical Research Consulting  will speak at the Medical Foods Industry Conference & Expo ( www.mfice.com ) on August 6-7, 2015 at the Miami Beach Convention Center.
 
Alan S. Ryan, Ph.D., CEO at Clinical Research Consulting will present on the clinical research and product development opportunities for medical foods. New medical food products containing omega-3 fatty acids will be described for a variety of medical conditions.

Efficacy claims for medical foods must be based on recognized scientific principles and sound laboratory and clinical data. Medical foods must be comprised of components designated as “Generally Recognized as Safe (GRAS).” The standard for an ingredient to achieve GRAS status requires not only technical demonstration of non-toxicity and safety, but also general recognition and agreement on that safety by experts in the field. There is an expectation that a medical food will help in treatment of a medical condition.  It is not simply a part of an overall diet designed to reduce the risk of a disease or medical condition, to lose or maintain weight, or to ensure the consumption of a healthy diet.
 
Video:  http://www.youtube.com/watch?v=fr8-6uZrBI0

The emerging medical foods market is USD $1.3 billion annually with strong growth potential. As a distinct, FDA-regulated category, medical foods are gaining more widespread acceptance.  However, they remain poorly understood by patients, pharmacists and physicians.
 
MFICE is the industry’s first organization providing a venue for the market’s innovators and thought leaders to meet, network, and discuss the industry’s strategies, regulations and growth.  
 
 
ABOUT CLINICAL RESEARCH CONSULTING
 
We provide consulting services for all aspects of clinical and preclinical research including protocol development, CRO selection, IRB submissions, data interpretation, final study report writing, publications, orphan drug submissions, and FDA correspondence and submissions.

Therapeutic areas: cardiovascular, pain, CNS, cognitive function, pediatrics, drug abuse

Areas of expertise: omega-3 fatty acids, nutrition, enteral and parenteral feeding, infant formulas, publication writing, clinical site monitoring, regulatory submissions, drug development

Clients: Big pharmaceutical and start-up companies dealing with drug development, dietary supplements, OTC pain medications, drug abuse screening, 505(b)(2) applications, IRB approvals for clinical studies, protocol development, preclinical safety studies, and peer-reviewed publications
 
 
ABOUT THE MEDICAL FOODS INDUSTRY CONFERENCE & EXPO
 
The Medical Foods Industry Conference & Expo is the first ever trade show and convention discussing the medical foods industry.  MFICE plans to generate new ideas and collaboration between various entities. Discussions of R&D, outreach, clinical research studies, market standards for products, retail versus prescription channels, current usage by various healthcare professionals and facilities, opportunities and obstacles for market growth, and insurance coverage are some of the topics that will be covered at this important summit.
 
For more information, please visit the website www.mfice.com or contact:
 
Marketdata Enterprises, Inc.
Phone: 813-907-9090
Fax: 813-907-3606
 
Ticonderoga Ventures, Inc.
Media, Marketing and Logistics Representative
Tel/ Fax: USA +1 (212) 722-1744 ext 89
E-mail: info-18@mfice.com
 

This press release may contain forward-looking statements, particularly as related to the business plans of the company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections. Actual results may differ materially from the company’s expectations and estimates.


( Press Release Image: http://photos.webwire.com/prmedia/32265/198752/198752-1.png )


WebWireID198752




 
 Meidical Foods
 RX Foods
 Alan S Ryan
 Conference
 omega-3 fatty acids


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.